Free U.S. Shipping on Orders $100+•$10 Flat-Rate Shipping Under $100
BACK TO LIBRARY
CELLULAR & REGENERATIVE RESEARCH

GHK-Cu

Also known as: Copper peptide · Glycyl-L-histidyl-L-lysine copper

Copper-Binding Tripeptide

EVIDENCE: EARLYLABORATORY AND SMALL TOPICAL HUMAN STUDIESFOR RESEARCH PURPOSES ONLY.
QUICK FACTS

COMPOUND CLASS

Naturally occurring copper-binding tripeptide

PRIMARY PATHWAY

Copper transport, collagen synthesis, and gene-expression modulation

PRIMARY AREAS OF RESEARCH

Skin remodeling, wound-healing biology, collagen signaling

RESEARCH STATUS

Laboratory and small topical human studies

EVIDENCE LEVEL

Early

OTHER NAMES

Copper peptide, Glycyl-L-histidyl-L-lysine copper

What Is GHK-Cu?

GHK-Cu is a small peptide made of three amino acids — glycine, histidine, and lysine — bound to a copper ion. The peptide occurs naturally in human blood plasma, and levels measured in plasma decline with age.

Copper is not incidental here. The body needs copper as a cofactor, meaning certain enzymes cannot function without it. GHK binds copper tightly, and the resulting complex is thought to deliver copper in a form cells can use. That combination of peptide plus mineral is what is actually studied.

What it is
A three-amino-acid peptide that binds copper, found naturally in human blood plasma.
Category
Regenerative and dermatology research peptide.
Main system involved
Skin fibroblasts, collagen production, and copper-dependent enzymes.
Research interest
Skin remodeling, wound healing, antioxidant enzymes, and gene expression.
Research status
Decades of cell-culture and animal research; human cosmetic studies exist but are generally small.

Why Are Researchers Interested?

PRECLINICAL RESEARCH

Consistent effects in cell studies

Fibroblasts in culture reliably increase collagen and related matrix production when exposed to GHK-Cu. This is well replicated at the cell level.

EARLY CLINICAL RESEARCH

Wound-healing research

Animal studies have examined tissue repair and new blood vessel formation.

PRECLINICAL RESEARCH

Gene-expression findings

Broad gene-profiling studies report changes across many pathways, which is why it is described as a modulator rather than a single-target compound.

LIMITED RESEARCH

Copper-dependent enzymes

Enzymes involved in connective-tissue crosslinking and antioxidant defense require copper, linking the peptide to established biochemistry.

How It Works

Skin gets its firmness from collagen and elastin, structural proteins made by cells called fibroblasts. In laboratory dishes, adding GHK-Cu prompts fibroblasts to produce more of these proteins.

The copper part matters because several enzymes need copper to work — including one that cross-links collagen fibers so they hold together, and one that neutralizes damaging molecules. The peptide is studied as a delivery vehicle that hands copper to the cells that need it, while also acting as a signal in its own right.

Current Areas of Research

LABORATORY RESEARCH

Collagen production

How fibroblasts respond by making more structural protein in cell culture.

HUMAN CLINICAL RESEARCH

Wound repair

Tissue healing and new blood vessel formation in animal models.

ANIMAL RESEARCH

Antioxidant defense

How copper-dependent enzymes reduce oxidative damage.

THEORETICAL MECHANISM

Hair follicle biology

Signaling in the cells at the base of hair follicles.

LABORATORY RESEARCH

Gene expression

Broad profiling studies showing shifts across many cellular pathways.

What Does the Evidence Actually Say?

EARLY

Early — extensive cell and animal work plus small human cosmetic studies exist, but large independent randomized trials are limited.

Side Effects & Safety Research

NEUTRAL SUMMARY OF PUBLISHED SAFETY RESEARCH

Documented in research

  • Topical studies generally report good local tolerability, with occasional irritation.

Possible or theoretical

  • Copper handling could theoretically matter with very large or systemic exposure.

Where evidence is insufficient

  • Injectable or systemic human safety data is not established.

What We Don't Know Yet

LIMITS OF THE CURRENT EVIDENCE
  • Human clinical evidence is limited and studies are typically small, short, and cosmetic in focus.
  • How well the peptide penetrates intact skin from topical formulations is debated.
  • Cell-culture effects do not automatically translate to living tissue.
  • Long-term effects and optimal formulation remain unresolved.

Frequently Asked Questions

Research References

  • Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2015.
  • Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 2018.
  • Maquart FX et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters, 1988.

Key Takeaway

KEY TAKEAWAY

GHK-Cu is a naturally occurring copper-binding peptide studied for decades in skin and wound-healing research. Cell-culture studies consistently show increased collagen and matrix production, and copper's role as an enzyme cofactor gives the findings a plausible biochemical basis. Human evidence is more limited, so it remains a well-established laboratory subject with ongoing questions about real-world skin effects.

Related Research

This information is provided for educational purposes only and summarizes current areas of scientific research. It is not medical advice, a treatment recommendation, or an instruction for personal use. Research findings may be preliminary, limited, or subject to change as new evidence becomes available.